High-dose chemotherapy and autologous stem cell transplant in elderly patients with primary CNS lymphoma: a pilot study

Blood Adv. 2020 Jul 28;4(14):3378-3381. doi: 10.1182/bloodadvances.2020002064.

Authors

Elisabeth Schorb¹, Benjamin Kasenda², Gabriele Ihorst^{1

3}, Florian Scherer¹, Julia Wendler⁴, Lisa Isbell¹, Heidi Fricker¹, Juergen Finke¹, Gerald Illerhaus⁴

Affiliations

¹ Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
² Department of Medical Oncology, University Hospital Basel & University of Basel, Basel, Switzerland.
³ Clinical Trials Unit, Faculty of Medicine, University of Freiburg, Freiburg, Germany; and.
⁴ Department of Hematology, Oncology and Palliative Care, Klinikum Stuttgart, Stuttgart, Germany.

Abstract

Age-adapted high-dose chemotherapy and autologous stem cell transplantation is safe and highly effective in elderly patients with PCNSL.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Aged
Central Nervous System Neoplasms* / therapy
Humans
Lymphoma, Non-Hodgkin* / therapy
Pilot Projects
Stem Cell Transplantation